Klaryvid 250 mg. 500 mg. FC tablets.
PDF Leaflet Revision Date: 10 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate severe infections.
Dosage (summary)
Adults: 250 mg twice daily; severe infections: 500 mg twice daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; excreted in breast milk.
Key Drug Interactions
- Ergot alkaloids
- Oral midazolam
- Statins (lovastatin, simvastatin)
- Colchicine
Contraindications
- Hypersensitivity to macrolides
- QT prolongation history
- Severe hepatic failure
Common side effects
- Nausea
- Diarrhea
- Headache
- Rash
Counselling Points
- Take with or without food
- Monitor for signs of liver dysfunction
- Avoid alcohol
Serious warnings
- QT prolongation risk
- Hepatic dysfunction
- Pseudomembranous colitis
Important Disclaimer
The Klaryvid 250 mg. 500 mg. FC tablets. professional information leaflet below is the property of Unimed Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
